Adherence to a risk‐adapted screening strategy for prostate cancer: First results of the PROBASE trial

PROBASE is a population‐based, randomized trial of 46 495 German men recruited at age 45 to compare effects of risk‐adapted prostate cancer (PCa) screening starting either immediately at age 45, or at a deferred age of 50 years. Based on prostate‐specific antigen (PSA) levels, men are classified int...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2023-03, Vol.152 (5), p.854-864
Hauptverfasser:	Krilaviciute, Agne, Albers, Peter, Lakes, Jale, Radtke, Jan Philipp, Herkommer, Kathleen, Gschwend, Jürgen, Peters, Inga, Kuczyk, Markus, Koerber, Stefan A., Debus, Jürgen, Kristiansen, Glen, Schimmöller, Lars, Antoch, Gerald, Makowski, Marcus, Wacker, Frank, Schlemmer, Heinz, Benner, Axel, Giesel, Frederik, Siener, Roswitha, Arsov, Christian, Hadaschik, Boris, Becker, Nikolaus, Kaaks, Rudolf
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Biopsy compliance contamination Early Detection of Cancer - methods Humans Magnetic resonance imaging Male Mass Screening - methods Medical research Middle Aged Prostate cancer Prostate-Specific Antigen Prostatic Neoplasms - diagnosis Prostatic Neoplasms - pathology PSA Risk Factors Risk groups screening
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!